(PharmaNewsWire.Com, September 06, 2019 ) OG Analysis, a global market research firm, has announced the release of their “Global Clinical Decision Support System Market Size, share, Outlook and Growth Opportunities to 2025: By Component (Services, Software, and Hardware), By Product (Integrated CDSS, Standalone CDSS), By Type (Therapeutic Clinical Decision Support Systems, Diagnostic Clinical Decision Support Systems), By Application (Conventional Clinical Decision Support Systems, Advanced Clinical Decision Support Systems) and By Region” Report proposes complete outlook of the market including comprehensive market analysis, Market Share, Market Size, Market Drivers, Challenges and Opportunities.
Government initiatives, increasing prevalence of medical errors, increased deployment of Information Technology (IT) in automation processes such as transaction, saving inventory and maintain records are driving the demand. Further, the use of clinical decision support systems increased extensively due to the improvements in productivity and performance, reduced medical errors, and enhanced quality of services across hospitals. Availability of big data-enabled integrated technologies with clinical decision support systems is also a driving factor. In addition, cloud-based clinical decision support systems (CDSS) coupled with the adoption of cloud computing may accelerate the market size in the upcoming years.
Services segment leads the global clinical decision support systems market followed by software and hardware. The services segment includes the services for supporting the installation, maintenance, and operations of clinical decision support systems (CDSS). Further, increasing patients admitted in hospitals with respect to increased prevalence of chronic diseases is likely to increase the market share of service segment. In addition, increased deployment of clinical decision support systems (CDSS) across hospitals, clinics, research organisations, and other settings are accelerating the demand for services.
Integrate clinical decision support systems holds the major market share due to hospitals and clinics utilising the integrated solutions. These integrated clinical decision support systems comprise of various interlinked applications that share common databases and user interfaces. Recent innovations in integrated clinical support decision systems to avail the databases of patients and medical professionals are also boosting the market size. Further, integrate clinical decision support systems benefits the organisations and hospitals with saving time by reducing decision cycle time, improve operational time in organising data, and others.
Therapeutic CDSS accounted for a major share followed by diagnostics CDSS during the forecast period 2019 to 2025. Rising usage of clinic decision support systems for treating therapeutics in both the hospitals, clinics and other facilities are driving the market size. The therapeutic CDSS perform various operations such gives data for healing therapies regarding treatments, dosage risks and medication, allergies, and others that can enhance the health condition of patients. Further, rise in human-based errors, medication errors, increase in population suffering from chronic diseases, and emerging focus on quality healthcare are boosting the demand.
Increase in hospitals, clinics, and other facilities and high adoption of clinical decision support systems (CDSS) drives the global market. Furthermore, conventional clinical decision support systems simplify physical order entry of the physicians to make choice of prescription from their database. In addition, CDSS companies are collaborating with hospitals and clinics to offer the products and services accelerate the market size.
North America dominates the global clinical decision support system market in 2019. The factors such as enhanced healthcare and medical infrastructure increase in medical spending of consumers, and government initiatives & investments are encouraging the emergence of clinical decision support systems. The key players in North America are forming collaborations, partnerships, and mergers to avail development of software upgrade. Further, government initiatives to encourage the adoption of CDSS integrated with EHR systems are estimated to drive the demand in future. Rapid technology advancements and launch of new products are the key strategies adopted by CDSS manufacturers in the North American region.
About OG Analysis: OG Analysis has been a trusted research partner for 10+ years delivering most reliable analysis, information and innovative solutions. OG Analysis is one of the leading players in market research industry serving 980+ companies across multiple industry verticals. Our core client centric approach comprehends client requirements and provides actionable insights that enable users to take informed decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
